The author, who holds Novo shares, cites Morgan Stanley's $190 billion obesity market forecast for 2035 and an NIH-funded mouse study on aging.
Recap by typeshit. Full story at Yahoo Finance.
TIKR points to retatrutide, due for filing in early 2027, and says a pending Seventh Circuit ruling on whether it counts as a biologic could decide 5 vs 12 years of exclusivity.
She lost 7 kilos in her first month, regained it during a month-long break, and now says she's eating more and gaining in week two back.
A shared report on doctors turning to GLP-1 medications for weight loss in some kids. Details are thin, so tap through for the full story.
The chain says it is exploring concepts including grilled items aimed at GLP-1 users, a sign of how the drugs are shifting food businesses.
MedPage Today
A JAMA Psychiatry network meta-analysis covering 5,898 people with schizophrenia found semaglutide and metformin reached at least 5% weight loss.
A pharmacist writes that FDA scientists recommended against all seven peptides reviewed, and warns the policy could weaken incentives to run real trials.
Loading…